Ex Vivo Expansion and Differentiation of Unselected Peripheral Blood Progenitor Cells in Serum-Free Media
- 1 December 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 7 (6) , 481-491
- https://doi.org/10.1089/scd.1.1998.7.481
Abstract
The ability to expand and differentiate unselected PBPC was investigated. Cells were grown in serum-free media containing stem cell factor, GCSF and megakaryocyte growth and development factor (pegylated PEG-rHuMGDF) with or without supplemental serum. Optimal proliferation occurred when PBPC were cultured without prior Ficoll-Paque separation in serum-free media. Cell yields after 17 days of culture were proportional to the percentage of CD34+ cells in the starting population and were 1170 ± 302-fold higher than the starting numbers of CD34+ cells. Granulocyte-macrophage colony-forming units increased over 12 days of culture, whereas the numbers of erythroid colony-forming cells peaked between 4 and 7 days. Elimination of PEG-rHuMGDF from cell cultures resulted in significantly lower yields of myeloid and erythroid colony-forming cells and total cell numbers. Cell differentiation into neutrophils was indicated by progressive increases in CD11b, CD15, and CD66b expression. Expanded neutrophils phagocytosed and killed bacteria as efficiently as neutrophils from normal donors. Large-scale expansion studies yielded similar proliferation and differentiation results as parallel small-scale cultures. Therefore, unselected PBPC can be efficiently expanded and differentiated into large numbers of functional mature neutrophils.Keywords
This publication has 27 references indexed in Scilit:
- CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimensBone Marrow Transplantation, 1997
- Thrombopoietin‐Stimulated ex Vivo Expansion of Human Bone Marrow MegakaryocytesThe International Journal of Cell Cloning, 1996
- Large Volume Ex Vivo Expansion of CD34-Positive Hematopoietic Progenitor Cells for TransplantationJournal of Hematotherapy, 1995
- Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex VivoNew England Journal of Medicine, 1995
- Bioreactor Expansion of Human Bone Marrow: Comparison of Unprocessed, Density-Separated, and CD34-Enriched CellsJournal of Hematotherapy, 1995
- Production of functional myeloid cells from CD34‐selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion systemThe International Journal of Cell Cloning, 1994
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.Proceedings of the National Academy of Sciences, 1988
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells.Journal of Clinical Investigation, 1981